Human neural stem cells: Phase II discontinued

StemCells will wind down operations after a DMC concluded that data from the single-blind Phase II Pathway Study of HuCNS-SC cells failed the futility

Read the full 245 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE